Managed Healthcare Executive September 7, 2021
For an assortment of reasons, the federal government hasn’t taken any action on regulating drug prices, so a handful of states have taken matters into their own hands.
For an assortment of reasons, the federal government hasn’t taken any action on regulating drug prices, so a handful of states have taken matters into their own hands. New York, Massachusetts, Maine, Maryland and New Hampshire have established entities with drug pricing powers. Harvard Medical School researchers published an informative overview of the state government efforts in the Milbank Quarterly in August.
As happens when healthcare policy devolves to the states, there’s a lot of variety in how the state-level drug pricing regulation is playing out. The Maine and New Hampshire drug...
Today's Sponsors
Today's Sponsor